Judge Rules Mylan Did Not Infringe Novo Nordisk Patent In Wegovy Generic Case

benzinga.com/news/legal/25/07/46635233/judge-rules-mylan-did-not-infringe-novo-nordisk-patent-in-wegovy-generic-case

Court grants Mylan judgment of no direct, contributory or induced infringement on U.S. Patent.
- Mylan’s proposed drug label did not instruct use without other therapeutic agents, undermining Novo’s case.
- Up Next: Get 5 Dark Horse Stocks Wall Street Is Quietly Loading Up On
The Novo…

This story appeared on benzinga.com, 2025-07-25 15:28:46.
The Entire Business World on a Single Page. Free to Use →